The 21-hydroxylation of progesterone to deoxycorticosterone (DOC) and of 17-hydroxyprogesterone to l1-deoxycortisol 
Introduction
The pathways ofadrenal and gonadal steroid hormone synthesis were traditionally examined by studying the kinetics of precursor-product relationships, leading to the conclusion that each steroidal conversion required a separate and specific enzyme or enzymes (1) . However, recent advances in enzyme purification leading to the cloning of cDNAs and genes for these enzymes have now greatly modified this view by showing that each steroidogenic enzyme can perform multiple steps (2) . A subtle corollary of this conclusion is that any single steroidogenic step need not necessarily be mediated by only one enzyme. In this report we prove this corollary by demonstrating that extraadrenal tissues having 2 1-hydroxylase activity lack the mRNA for the adrenal 2 1-hydroxylase, P450c2 1.
Steroid 2 1-hydroxylation has been studied in considerable detail, in part because congenital adrenal hyperplasia due to defective adrenal 2 1-hydroxylation affects -1 of 10,000 persons. A single specific form of cytochrome P450, termed P450c21, mediates the 2 1-hydroxylation of both progesterone and 17-hydroxyprogesterone (170HP)' to deoxycorticosterone (DOC) and 1 1-deoxycortisol, respectively (3) . The cDNA and genes for P450c21 have been cloned and characterized from several species (reviewed in reference 2) and the disorders of the human 21 -hydroxylase gene locus associated with congenital adrenal hyperplasia have been studied in detail by numerous groups (4) .
Steroid 2 1-hydroxylation also occurs in a wide variety of human adult and fetal extraadrenal tissues, which take up circulating progesterone and convert it to DOC or DOC sulfate (reviewed in reference 5). The nature ofthe enzyme(s) mediating this extraadrenal 2 1-hydroxylase activity is unknown. Some studies suggest that P450c21 might be the extraadrenal 2 1-hydroxylase, but others do not. Authentic P450c21 mRNA was found in mouse liver by molecular cloning (6), in bovine testis by hybridization of RNA to cloned cDNA followed by SI nuclease digestion (7) , and in a human Leydig cell adenoma by Northern blotting (8) . By contrast, rabbit hepatic 2 1-hydroxylation is mediated by P450-1, which is structurally unrelated to P450c21 (9) , and P450c21 mRNA was not detected in human fetal tissues by a relatively insensitive Northern blotting procedure that had difficulty detecting adrenal P450c21 mRNA (10) . Extraadrenal 21-hydroxylation persisted in one patient with adrenal hyperplasia due to 2 1-hydroxylase deficiency, but this patient had an incomplete enzymatic defect and retained the ability to 2 1-hydroxylate progesterone to DOC in her adrenal (11) . Thus, the nature of the enzyme(s) mediating extraadrenal 21 -hydroxylation and the presence or absence of P450c21 mRNA in extraadrenal human tissues have been unclear. To determine if human fetal extraadrenal tissues contained enough P450c21 mRNA to account for their high levels of 21 -hydroxylase activity (12) we examined RNA from such tissues by solution hybridization and nuclease protection.
Methods
RNA preparation. Human fetal tissues were obtained from elective early second trimester cervical dilatation and evacuation under approved protocols of the Department of Obstetrics, Gynecology, and Reproductive Sciences at the University of California, San Francisco. Fetal tissues were frozen in liquid N2 and used to prepare RNA as described (13) , except that ultracentrifugation was done in a TLS-55 rotor (Beckman Instruments, Inc., Palo Alto, CA) at 50,000 rpm for 4 h, and each tube contained a 0.5-ml cushion of 5.7 M CsCl and 2.0 ml of tissue lysis solution. Rat tissues were stored frozen in liquid N2 and used for RNA preparation by the LiCl precipitation procedure (14 RNase V, treatment. 5 tg of rat adrenal RNA mixed with 45 'sg of yeast tRNA were hybridized to the 1,275-base human P450c21 probe as described above. RNase A at 1 Ag/ml and RNase VI 0-3,500 mU/ml were added in 20 mM Tris HCl (pH 7.2), 200 mM NaCl and 10 mM MgCl2 (18) . Samples were then treated with proteinase K and NaDodSO4 and analyzed as described above.
Results
Distribution of P45Oc21 mRNA in human fetal tissues. Because extraadrenal 21 -hydroxylase activity is greater in human fetal tissues than in adult tissues (12) , we examined the same fetal tissues studied by Casey et al. (12 We have previously detected abundant P450c21 mRNA in bovine testis by S. nuclease protection experiments (17) , and also recently detected trace amounts of P450c21 mRNA in a human Leydig cell adenoma (8) . Furthermore, guinea pig spleen has been identified as an especially rich source of extraadrenal 2 1-hydroxylase (19) . Therefore, since these tissues had not been available when the experiment in Fig. 1 was done, we studied these tissues in a separate experiment using SI nuclease protection. As seen in Fig. 2 , human fetal adrenal RNA protected the expected 387-base fragment of the probe from digestion, but RNA from fetal testis and spleen did not; even when this autoradiograph was overexposed, no bands of SI-protected probe were seen with the fetal testis or spleen RNA (Fig. 2, right) . Distribution ofP45Oc2J mRNA in adult rat tissues: use of heterologous sequence probes for RNase protection. As the rat is the most widely used experimental animal for studying steroidogenesis, we wished to determine if the rat expressed P450c21 mRNA outside the adrenal. Rat P450c21 cDNA has not been cloned, but our demonstration of a highly conserved putative steroid-binding site, in addition to the known species conservation of the heme-binding site in steroidogenic P450s (20) , suggested that some regions of the rat and human P450c21 sequences would be sufficiently similar (i.e., nearly identical) to yield hybrids resistant to RNase A. In the absence of a known rat P450c21 sequence, the number, length, and location of the regions of high similarity between rat and human P450c21 could not be determined. Therefore, we used a much longer human riboprobe for these heterologous sequence hybridizations than the 173 bases of human P450c21 used in Fig. 1 . As shown in Fig. 3, when Fig. 3 were truly due to specific RNA/RNA hybridization and did not represent an artifact (e.g., contamination ofthe adrenal RNA with genomic DNA). We first hybridized rat adrenal RNA to the human riboprobe and digested the mixture with RNase A, as was done in Fig. 3 . Aliquots of this material were then digested with increasing amounts of RNase VI, which only digests doublestranded RNA but not single-stranded RNA, RNA/DNA hybrids, or DNA. As seen in Fig. 4 , all of the radioactivity protected by rat adrenal RNA from digestion with RNase A could be digested with RNase VI. By contrast, the minimal amount of radioactivity that remained after RNase A treatment of probe hybridized to yeast tRNA remained after RNase VI digestion. This indicates that the background seen in the hybridization with yeast tRNA or with the rat nonadrenal tissues was simply due to small amounts of undigested single-stranded fragments of the probe, or probe hybridizing to trace amounts of template DNA. Thus, the use of riboprobes from heterologous species for RNase A protection experiments can yield highly specific and exquisitely sensitive detection of certain species of mRNA.
Discussion
Although extraadrenal 2 1-hydroxylation has been found in all mammals examined for this activity, its biochemical basis and role have been unknown (5) . In the human fetus extraadrenal 2 1-hydroxylase activity is widely distributed and may exceed the activity found in the fetal adrenal (12) . The studies we have presented show that these tissues can contain no more than 0.01 % of the P450c21 mRNA found in the fetal adrenal. Thus, even if there is some P450c21 mRNA in these extraadrenal tissues at concentrations below the sensitivity of our assay, it is clear that the encoded P450c21 protein cannot account for the abundant 2 1-hydroxylase activity found in human fetal extraadrenal tissues.
Some patients who have been described having severe, salt-wasting 21 -hydroxylase deficiency nonetheless recover the capacity to make enough mineralocorticoids to avoid a saltlosing crisis in adult life (21, 22) . While this encouraged speculation that the enzymes mediating the 2 1-hydroxylation of progesterone to deoxycorticosterone and of 170HP to 11-deoxycortisol were different (22) , the demonstration that there is only one P450c21 involved in adrenal 2 1-hydroxylation has ruled this out (2) (3) (4) . By contrast, we would propose that chronically elevated circulating concentrations of progesterone and 170HP, possibly in concert with other factors associated with hypovolemia (e.g., increased concentrations of renin and angiotensin II) might induce the extraadrenal 2 1-hydroxylase(s). Mineralocorticoids are required at 100-fold lower concentrations than glucocorticoids. Thus, even if extraadrenal 21 -hydroxylation is much less efficient than adrenal P450c21, a small induction of extraadrenal 21-hydroxylation might have a significant effect on mineral metabolism even in the face of continued evidence of glucocorticoid insufficiency.
This hypothesis fits both the clinical observations and the known molecular biology of 21 -hydroxylase. It must now be tested directly by determining the molecular identity of extraadrenal 2 1-hydroxylase(s).
